Insulin aspart, recombinant Subcutaneous and Mometasone nasal
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Mometasone nasal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: mometasone nasal
Brand name: Nasonex, Propel, Sinuva, Propel Mini, Propel Contour
Synonyms: Mometasone (Nasal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Mometasone Nasal Spray
- Insulin aspart, recombinant Subcutaneous-Mometasone Ointment
- Insulin aspart, recombinant Subcutaneous-Mometasone topical
- Insulin aspart, recombinant Subcutaneous-Mometasone Topical application
- Insulin aspart, recombinant Subcutaneous-Monarc-M
- Insulin aspart, recombinant Subcutaneous-Monistat 1 Combination Pack
- Mometasone nasal-Insulin degludec
- Mometasone nasal-Insulin Degludec (U-100) Prefilled Pens
- Mometasone nasal-Insulin Degludec (U-100) Vials
- Mometasone nasal-Insulin Degludec (U-200) Prefilled Pens
- Mometasone nasal-Insulin degludec and liraglutide
- Mometasone nasal-Insulin degludec and liraglutide Subcutaneous